TY - JOUR
T1 - Engineered Bionanomaterials for Precision Delivery of Nucleic Acid Drugs
AU - Bian, Xiaochun
AU - Luo, Zhiwei
AU - Peng, Bing
AU - Chen, Jiahui
AU - Lo, Pik Kwan
AU - Zhou, Liping
AU - Wen, Yongqiang
PY - 2025/10/23
Y1 - 2025/10/23
N2 - Engineered bionanomaterials, natural or engineered nano-scale biomaterials used in biomedical applications such as liposomes and polymer nanoparticles, have emerged as transformative platforms for targeted nucleic acid drug delivery, addressing critical challenges in precision therapeutics. These advanced biomaterials leverage their inherent biocompatibility, tunable surface chemistry, and nano-scale dimensions to overcome biological barriers while protecting nucleic acid payloads from enzymatic degradation. Recent breakthroughs in material functionalization strategies have enabled unprecedented spatial control, allowing precise targeting of specific tissues, cellular compartments, and even subcellular organelles. This review adopts a barrier-oriented and mechanism-driven framework to systematically examine the key delivery challenges associated with nucleic acid drugs and the rational design of nanocarriers to overcome them. It focuses on three critical dimensions: i) the structural categories and functional classifications of nucleic acid drugs; ii) design principles of representative engineered bionanomaterials; and iii) the physiological barriers encountered during delivery and strategies to overcome them through structural innovation and functional tuning. By integrating drug properties, delivery barriers, and material design into a unified conceptual framework, this review informs the development of next-generation delivery systems for precise and effective nucleic acid therapeutics.
© 2025 Wiley-VCH GmbH
AB - Engineered bionanomaterials, natural or engineered nano-scale biomaterials used in biomedical applications such as liposomes and polymer nanoparticles, have emerged as transformative platforms for targeted nucleic acid drug delivery, addressing critical challenges in precision therapeutics. These advanced biomaterials leverage their inherent biocompatibility, tunable surface chemistry, and nano-scale dimensions to overcome biological barriers while protecting nucleic acid payloads from enzymatic degradation. Recent breakthroughs in material functionalization strategies have enabled unprecedented spatial control, allowing precise targeting of specific tissues, cellular compartments, and even subcellular organelles. This review adopts a barrier-oriented and mechanism-driven framework to systematically examine the key delivery challenges associated with nucleic acid drugs and the rational design of nanocarriers to overcome them. It focuses on three critical dimensions: i) the structural categories and functional classifications of nucleic acid drugs; ii) design principles of representative engineered bionanomaterials; and iii) the physiological barriers encountered during delivery and strategies to overcome them through structural innovation and functional tuning. By integrating drug properties, delivery barriers, and material design into a unified conceptual framework, this review informs the development of next-generation delivery systems for precise and effective nucleic acid therapeutics.
© 2025 Wiley-VCH GmbH
KW - biological barriers
KW - engineered bionanomaterials
KW - targeted nucleic acid delivery
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001562142100001
U2 - 10.1002/smll.202502667
DO - 10.1002/smll.202502667
M3 - RGC 21 - Publication in refereed journal
SN - 1613-6810
VL - 21
JO - Small
JF - Small
IS - 42
M1 - e02667
ER -